| 1 | General Hospital Corporation | 461 | 5/5 | 91 | $71,406 |
| 2 | Brigham and Women's Hospital | 240 | 5/5 | 40 | $71,406 |
| 3 | Vertex Pharmaceuticals Incorporated | 100 | 5/5 | 26 | $109,699 |
| 4 | Takeda Development Center Americas, Inc. | 90 | 5/5 | 18 | $140,000 |
| 5 | Children's Hospital Corporation | 75 | 5/5 | 14 | $76,000 |
| 6 | Novartis Institutes for BioMedical Research, Inc. | 52 | 5/5 | 6 | $88,962 |
| 7 | Biogen, Inc. | 47 | 5/5 | 2 | $109,699 |
| 8 | Massachusetts Institute of Technology | 37 | 5/5 | 6 | $77,834 |
| 9 | TRUSTEES OF BOSTON UNIVERSITY | 36 | 5/5 | 7 | $75,000 |
| 10 | Massachusetts Eye and Ear Infirmary | 35 | 5/5 | 12 | $70,000 |
| 11 | ClearView Healthcare Partners, LLC | 34 | 5/5 | 6 | $125,000 |
| 12 | Harvard University | 33 | 5/5 | 5 | $81,900 |
| 13 | Sanofi US Services Inc. | 31 | 5/5 | 4 | $116,156 |
| 14 | Sarepta Therapeutics, Inc. | 31 | 5/5 | 2 | $121,000 |
| 15 | Beth Israel Deaconess Medical Center, Inc. | 28 | 3/5 | 17 | $75,000 |
| 16 | McLean Hospital | 27 | 5/5 | 4 | $70,279 |
| 17 | BioNTech US Inc. | 26 | 5/5 | 1 | $106,000 |
| 18 | The Broad Institute, Inc. | 25 | 5/5 | 2 | $100,000 |
| 19 | PFIZER INC. | 24 | 5/5 | 2 | $105,643 |
| 20 | Alnylam US, Inc. | 20 | 3/5 | 8 | $151,000 |
| 21 | ModernaTX, Inc. | 18 | 5/5 | 3 | $130,800 |
| 22 | Bristol-Myers Squibb Company | 17 | 5/5 | 5 | $154,727 |
| 23 | AstraZeneca Pharmaceuticals LP | 15 | 5/5 | 4 | $165,000 |
| 24 | Blueprint Medicines Corporation | 15 | 4/5 | 0 | $138,636 |
| 25 | Tessera Therapeutics, Inc. | 14 | 3/5 | 0 | $105,305 |
| 26 | Amgen Inc. | 13 | 4/5 | 1 | $131,229 |
| 27 | Dana-Farber Cancer Institute | 12 | 5/5 | 2 | $96,209 |
| 28 | HARVARD MEDICAL FACULTY PHYSICIANS AT BETH ISRAEL DEACONESS MEDICAL CENTER | 12 | 4/5 | 2 | $186,000 |
| 29 | Spaulding Rehabilitation Hospital | 11 | 5/5 | 5 | $71,750 |
| 30 | Sanofi Pasteur Inc. | 10 | 4/5 | 0 | $102,458 |
| 31 | Corixa Corporation | 9 | 3/5 | 4 | $89,925 |
| 32 | GlaxoSmithKline LLC | 9 | 4/5 | 4 | $130,000 |
| 33 | Seqirus Inc. | 9 | 3/5 | 0 | $120,000 |
| 34 | Vor Biopharma Inc. | 9 | 3/5 | 0 | $90,000 |
| 35 | Eli Lilly and Company | 9 | 3/5 | 3 | $155,328 |
| 36 | Flagship Pioneering, Inc. | 9 | 4/5 | 2 | $155,000 |
| 37 | ABBVIE BIORESEARCH CENTER INC. | 8 | 3/5 | 4 | $145,318 |
| 38 | Charles River Laboratories, Inc. | 8 | 3/5 | 3 | $102,649 |
| 39 | Foundation Medicine, Inc. | 8 | 4/5 | 1 | $93,891 |
| 40 | Genzyme Corporation | 8 | 5/5 | 2 | $159,409 |
| 41 | Massachusetts Eye and Ear Associates | 8 | 4/5 | 5 | $81,579 |
| 42 | Northeastern University | 8 | 4/5 | 1 | $68,203 |
| 43 | Tufts Medical Center | 8 | 2/5 | 0 | $68,467 |
| 44 | Generation Bio Co. | 7 | 2/5 | 0 | $105,000 |
| 45 | MCPHS University | 7 | 4/5 | 0 | $66,893 |
| 46 | Voyager Therapeutics, Inc. | 7 | 3/5 | 0 | $142,167 |
| 47 | Alexion Pharmaceuticals, Inc. | 6 | 4/5 | 2 | $189,480 |
| 48 | Bayer U.S. LLC | 6 | 3/5 | 0 | $119,257 |
| 49 | Cyprotex US, LLC | 6 | 3/5 | 0 | $111,000 |
| 50 | Ensoma, Inc. | 6 | 4/5 | 0 | $108,250 |
| 51 | Hebrew Rehabilitation Center | 6 | 2/5 | 0 | $102,055 |
| 52 | NOVARTIS PHARMACEUTICALS CORPORATION | 6 | 3/5 | 0 | $107,484 |
| 53 | Tufts Medical Center, Inc. | 6 | 3/5 | 3 | $74,600 |
| 54 | Baim Institute for Clinical Research | 5 | 3/5 | 0 | $65,000 |
| 55 | Entrada Therapeutics, Inc. | 5 | 3/5 | 0 | $150,000 |
| 56 | Foghorn Therapeutics, Inc. | 5 | 3/5 | 0 | $125,000 |
| 57 | Generate Biomedicines, Inc. | 5 | 2/5 | 0 | $120,000 |
| 58 | Health Advances, LLC | 5 | 4/5 | 0 | $120,000 |
| 59 | Joslin Diabetes Center, Inc. | 5 | 1/5 | 5 | $77,267 |
| 60 | Myeloid Therapeutics, Inc. | 5 | 2/5 | 0 | $90,000 |
| 61 | Replimune Inc. | 5 | 3/5 | 0 | $190,000 |
| 62 | Strand Therapeutics Inc. | 5 | 2/5 | 2 | $84,906 |
| 63 | UCB BioSciences Inc. | 5 | 2/5 | 3 | $106,870 |
| 64 | Zag Bio, Inc. | 5 | 3/5 | 2 | $130,000 |
| 65 | ABBVIE INC. | 4 | 3/5 | 0 | $142,500 |
| 66 | Apellis Pharmaceuticals, Inc. | 4 | 3/5 | 1 | $155,733 |
| 67 | Boston Medical Center Corporation | 4 | 3/5 | 0 | $90,886 |
| 68 | CRISPR Therapeutics, Inc. | 4 | 2/5 | 1 | $104,469 |
| 69 | EMD Serono Research and Development Institute, Inc. | 4 | 4/5 | 1 | $110,864 |
| 70 | Invicro, LLC | 4 | 3/5 | 0 | $93,050 |
| 71 | Joslin Diabetes Center | 4 | 2/5 | 0 | $70,073 |
| 72 | Keros Therapeutics | 4 | 3/5 | 0 | $210,000 |
| 73 | Moderna Services, Inc. | 4 | 3/5 | 1 | $103,446 |
| 74 | SalioGen Therapeutics | 4 | 3/5 | 0 | $79,460 |
| 75 | Takeda Vaccines Inc. | 4 | 3/5 | 1 | $87,488 |
| 76 | TCR2 Therapeutics, Inc. | 4 | 1/5 | 0 | $76,000 |
| 77 | Tufts University | 4 | 1/5 | 0 | $85,000 |
| 78 | Brigham and Women's Physicians Organization, Inc | 4 | 3/5 | 0 | $147,836 |
| 79 | ABBVIE BIORESEARCH CENTER | 3 | 2/5 | 0 | $130,000 |
| 80 | Arena BioWorks LLC | 3 | 1/5 | 0 | $105,000 |
| 81 | Axonis Therapeutics, Inc. | 3 | 1/5 | 0 | $130,000 |
| 82 | BLUEBIRD BIO, INC. | 3 | 2/5 | 0 | $235,000 |
| 83 | Brigham & Women's Faulkner Hospital | 3 | 1/5 | 0 | $85,000 |
| 84 | Cambridge Public Health Commission | 3 | 2/5 | 1 | $62,830 |
| 85 | Children's Hospital Pediatric Associates, Inc. | 3 | 2/5 | 0 | $140,000 |
| 86 | Cystic Fibrosis Foundation | 3 | 1/5 | 0 | $143,000 |
| 87 | Enanta Pharmaceuticals, Inc. | 3 | 2/5 | 0 | $123,198 |
| 88 | General Hospital Corp | 3 | 2/5 | 0 | $77,834 |
| 89 | Jounce Therapeutics, Inc. | 3 | 1/5 | 0 | $117,000 |
| 90 | KSQ Therapeutics, Inc. | 3 | 2/5 | 0 | $150,000 |
| 91 | Massachusetts General Physicians Organization | 3 | 2/5 | 0 | $86,350 |
| 92 | Montai Therapeutics, Inc. | 3 | 2/5 | 1 | $120,120 |
| 93 | Ocular Therapeutix, Inc. | 3 | 3/5 | 1 | $104,000 |
| 94 | Omega Therapeutics, Inc. | 3 | 1/5 | 0 | $77,625 |
| 95 | PPD Development, L.P. | 3 | 3/5 | 1 | $95,000 |
| 96 | Ring Therapeutics, Inc. | 3 | 2/5 | 1 | $83,250 |
| 97 | Sanegene Bio USA Inc. | 3 | 3/5 | 1 | $127,000 |
| 98 | Takeda Pharmaceuticals USA, Inc. | 3 | 3/5 | 1 | $150,000 |
| 99 | The Fountain Group, LLC | 3 | 3/5 | 0 | $117,832 |
| 100 | The General Hospital Corporation | 3 | 1/5 | 0 | $71,750 |